97-7506. Advisory Committee on the Medical Uses of Isotopes: Meeting Notice  

  • [Federal Register Volume 62, Number 57 (Tuesday, March 25, 1997)]
    [Notices]
    [Pages 14170-14171]
    From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
    [FR Doc No: 97-7506]
    
    
    -----------------------------------------------------------------------
    
    
    NUCLEAR REGULATORY COMMISSION
    
    Advisory Committee on the Medical Uses of Isotopes: Meeting 
    Notice
    
    AGENCY: U.S. Nuclear Regulatory Commission.
    
    ACTION: Notice of meeting.
    
    -----------------------------------------------------------------------
    
    SUMMARY: The U.S. Nuclear Regulatory Commission will convene a meeting 
    of the Advisory Committee on the Medical Uses of Isotopes on April 10-
    11, 1997. Topics will include discussions of: the Commission's Staff 
    Requirements Memorandum entitled ``Materials/Medical Oversight (DSI 
    7)''; NRC's Medical Policy Statement of 1979; criteria and racking of 
    medical procedures by risk; regulatory use of industry standards; 
    misadministrations; the advisory committee process; and status reports 
    on proposed rulemaking and guidance documents. In addition, on April 
    11, 1997, the members of the Committee will prepare for a May 15, 1997, 
    meeting with the Commissioners. The Commission briefing will be Noticed 
    separately.
    
    Location: The meeting will take place at the U.S. Nuclear Regulatory 
    Commission, Two White Flint North, 11545 Rockville Pike, Room T2B3, 
    Rockville, MD 20852-2738. All sessions of the meeting will be open to 
    the public.
    
    DATES: The meeting will begin at 8:30 a.m., on April 10, 1997, and 8:00 
    a.m. on April 11, 1997.
    
    ADDRESSES: U.S. Nuclear Regulatory Commission, Two White Flint North, 
    11545 Rockville Pike, Room T2B3, Rockville, MD 20852-2738.
    
    FOR FURTHER INFORMATION, CONTACT: William B. McCarthy, Ph.D., U.S. 
    Nuclear Regulatory Commission, Office of Nuclear Material Safety and 
    Safeguards, MS T8F5, Washington, DC 20555, Telephone (301) 415-7900.
    
    Conduct of the Meeting
    
        Judith Ann Stitt, M.D., will chair the meeting. Dr. Stitt will 
    conduct the meeting in a manner that will facilitate the orderly 
    conduct of business. The following procedures apply to public 
    participation in the meeting:
        1. Persons who wish to provide a written statement should submit a 
    reproducible copy to William B. McCarthy (address listed previously), 
    by April 4, 1997. Statements must pertain to the topics on the agenda 
    for the meeting.
        2. At the meeting, questions from members of the public will be 
    permitted at the discretion of the Chairman.
        3. The transcript and written comments will be available for 
    inspection, and copying, for a fee, at the NRC Public Document Room, 
    2120 L Street, N.W., Lower Level, Washington, DC 20555, telephone (202) 
    634-3273, on or about April 18, 1997. Minutes of the meeting will be 
    available on or about May 23, 1997.
    
    [[Page 14171]]
    
        4. Seating for the public will be on a first-come, first-served 
    basis.
        This meeting will be held in accordance with the Atomic Energy Act 
    of 1954, as amended (primarily Section 161a); the Federal Advisory 
    Committee Act (5 U.S.C. App); and the Commission's regulations in Title 
    10, U.S. Code of Federal Regulations, Part 7.
    
        Dated: March 19, 1997.
    Andrew L. Bates,
    Advisory Committee Management Officer.
    [FR Doc. 97-7506 Filed 3-24-97; 8:45 am]
    BILLING CODE 7590-01-P
    
    
    

Document Information

Published:
03/25/1997
Department:
Nuclear Regulatory Commission
Entry Type:
Notice
Action:
Notice of meeting.
Document Number:
97-7506
Dates:
The meeting will begin at 8:30 a.m., on April 10, 1997, and 8:00 a.m. on April 11, 1997.
Pages:
14170-14171 (2 pages)
PDF File:
97-7506.pdf